SUNDAY |
4:00 pm - 8:00 pm | Arrival and Check-in |
6:00 pm | Dinner |
7:30 pm - 7:40 pm | Welcome / Introductory Comments by GRC Site Staff |
7:40 pm - 9:30 pm | The Quest for Biocompatibility; Factors Effecting Thrombosis and Other Adverse Events |
| Discussion Leader: John Watson (UCSD) |
7:40 pm - 8:05 pm | Marvin Slepian (University of Arizona)
"Virchow's Triad Revisited!" |
8:05 pm - 8:15 pm | Discussion |
8:15 pm - 8:45 pm | Geert Schmid-Schonbein
"The Leaky Gut: Pancreatic Enzymes on the Prowl!"
|
8:45 pm - 8:55 pm | Discussion |
8:55 pm - 9:20 pm | Erik Taylor (Northeastern University)
"Could Nanotexturing and Nanotechnology for MCS reduce pump thrombosis"
|
9:20 pm - 9:30 pm | Discussion |
MONDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Basic Bioengineering Aspects to Reduce Severe Adverse Events Associated With Bleeding and Stroke |
| Discussion Leaders: George Wieselthaler (UCSF) and Walt Dembitsky (Sharpe Memorial, San Diego) |
9:00 am - 9:40 am | Scott Diamond (U of Penn)
"Predicting Blood Function: hemodynamics, pharmacology, and patient-specific biology"
|
9:40 am - 10:00 am | Discussion |
10:00 am - 10:30 am | Group Photo / Coffee Break |
10:30 am - 11:10 am | Egemen Tuzun (Texas A & M Institute For Preclinical Studies)
"Effect of Continuous and Induced Pulsatile Flow on the Gastrointestinal System: Implications for Gastrointestinal Bleeding"
|
11:10 am - 11:30 am | Discussion |
11:30 am - 12:10 pm | Robert Padera (Harvard/Brigham)
"Device-Mediated Inflammation: Does it Matter?"
|
12:10 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 5:30 pm | Poster Session |
5:30 pm - 7:30 pm | LVAD Utilization and Associated Cost |
| Discussion Leaders: Tim Baldwin (NHLBI) and Robin Bostic (Thoratec Corporation) |
5:30 pm - 6:10 pm | Keith Aaronson (U. Michigan) & Joe Rogers (Duke)
"Point / Counterpoint on Revive-IT: Are we really at equipoise For VADing class III / IIIB Patients?"
|
6:10 pm - 6:30 pm | Discussion |
6:30 pm - 7:10 pm | Robin Bostic (Thoratec)
"Can We Afford New Innovative Technology"
|
7:10 pm - 7:30 pm | Discussion |
8:00 pm | Dinner |
TUESDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Right Heart Function and Failure in Long Term Mechanical Circulatory Support: Getting Back to Basics |
| Discussion Leaders: Eduardo Rame (U of Penn) and Frank Pagani (U of Michigan) |
9:00 am - 9:30 am | Michael Bristow (UC Denver)
"Intact heart gene expression changes in the failing RV, and response to reverse remodeling with beta-blocking agents" |
9:30 am - 9:35 am | Discussion |
9:35 am - 10:05 am | J. Eduardo Rame (U of Penn)
"Getting to Know the RV: Differential Gene Expression in the RV Response to Failure and LV Mechanical Unloading" |
10:05 am - 10:20 am | Discussion |
10:20 am - 10:50 am | Coffee Break |
10:50 am - 11:20 am | James Kirkpatrick (University of Pennsylvania, Philadelphia, PA)
"RV Function on LVAD Support : What does the Long Term Look Like"
|
11:20 am - 11:40 am | Discussion |
11:40 am - 12:10 pm | Martin Strueber (Leipzig)
"Strategies to Manage Early and Late Right Heart Failure After LVAD Support"
|
12:10 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 5:30 pm | Poster Session |
5:30 pm - 7:30 pm | Assisted Circulation for Evolving Patient Groups |
| Discussion Leaders: Peter Wearden (U. Pittsburgh) and Patti Massicotte (U of Alberta, Canada) |
5:30 pm - 5:50 pm | Tim Baldwin (NHLBI)
"The Pitfalls and Potential Of Advanced Technology used in MCS devices For Children"
|
5:50 pm - 6:00 pm | Discussion |
6:00 pm - 6:20 pm | Christina VanderPluym (CH of Boston)
"Are We Winning? Why we need PEDIMACS and what we've learned"
|
6:20 pm - 6:30 pm | Discussion |
6:30 pm - 6:50 pm | Mark Rodefeld (Indiana U)
"The growing Need for Assisted Circulation In Adult Fontan Patients and Bioengineering and Clinical Options to Address it"
|
6:50 pm - 7:00 pm | Discussion |
7:00 pm - 7:20 pm | Charles Fraser (Baylor College of Medicine, Texas Children's Hospital)
"The Challenges of Treating and Managing Adult Fontan and Pediatric Patients with MCS Devices"
|
7:20 pm - 7:30 pm | Discussion |
8:00 pm | Dinner |
WEDNESDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Clinical Considerations for increase Use of LVAD'S |
| Discussion Leaders: Joseph Rogers (DUKE) and Meredith Brisco (U of Penn) |
9:00 am - 9:20 am | Lynne Stevenson (Harvard / Brigham)
"Critical Data Elements for VAD Registries and Quality Assurance/Performance Improvement Programs"
|
9:20 am - 9:30 am | Discussion |
9:30 am - 10:00 am | David Naftel (U of Alabama) and Andy Boyle (CCF Florida)
"Have We Met Our Goal to Use INTERMACS Data as the Control Group" |
10:00 am - 10:20 am | Discussion |
10:20 am - 10:50 am | Coffee Break |
10:50 am - 11:20 am | Mark Slaughter (U of Louisville)
"What are the clinical contraindications to Destination Therapy in the current era?"
|
11:20 am - 11:40 am | Discussion |
11:40 am - 12:10 pm | Todd Dardas (U of Washington, Seattle)
"When should VAD patients be transplanted and with what priority?"
|
12:10 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 5:30 pm | Poster Session |
5:30 pm - 7:30 pm | Clinical Trial Design |
| Discussion Leader: Jim Long (Integris Adv. C. Care) |
5:30 pm - 6:10 pm | Clyde Yancey (Northwestern U.)
"The Definitive All-Indication (BTT / DT / BTD / etc.) VAD trial Design from a clinicians point of view"
|
6:10 pm - 6:30 pm | Discussion |
6:30 pm - 7:10 pm | Ileana Pina (Montefiore)
"Moving Toward a Single Indication for VAD Support: an FDA Perspective"
|
7:10 pm - 7:30 pm | Discussion |
7:30 pm - 8:00 pm | Business Meeting |
| Nominations for the next Vice Chair; Fill out Conference Evaluation Forms; Discuss future Site & Scheduling preferences; Election of the next Vice Chair |
8:00 pm | Dinner |
THURSDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am - 12:30 pm | Advancements in Sensor Technology, Power Transmission and the Understanding of LVAD Limitations |
| Discussion Leaders: Henrich Schima (Med. U of Vienna) and Tim Kaufmann (Helmholtz - Institute, Aachen Germany) |
9:00 am - 9:40 am | Thorsten Siess (Abiomed)
"Sensors for VADs : Challenges, Achievements and Clinical Experiences"
|
9:40 am - 10:00 am | Discussion |
10:00 am - 10:30 am | Coffee Break |
10:30 am - 11:10 am | Pramod Bonde (Yale School of Medicine, New Haven, CT)
"The Future Technology of Far Distance Power Transmission Into the Biologic System"
|
11:10 am - 11:30 am | Discussion |
11:30 am - 12:10 pm | Uwe Tegtbur (Hannover)
"Limitation of Exercise in VAD patients; physiological aspects from sports physiology"
|
12:10 pm - 12:30 pm | Discussion |
12:30 pm | Lunch |
1:30 pm - 4:00 pm | Free Time |
4:00 pm - 5:30 pm | Poster Session |
5:30 pm - 7:30 pm | The Future of MCS, Rotary Blood Pumps and the Clinical Considerations |
| Discussion Leader: Donna Mancini (Columbia University) |
5:30 pm - 5:55 pm | Richard Wampler (R & A design)
"Innovations in Rotary Blood Pump Designs" |
5:55 pm - 6:05 pm | Discussion |
6:05 pm - 6:30 pm | Bud Frazier (THI, Houston TX)
"The Future of MCS - The next steps" |
6:30 pm - 6:40 pm | Discussion |
6:40 pm - 6:55 pm | Robert Kormos (University of Pittsburgh)
"Future National and International Requirements for Accreditation of VAD Clinicians" |
6:55 pm - 7:05 pm | Discussion |
7:05 pm - 7:20 pm | James Kirklin (U of Alabama)
"The Future Role of INTERMACS" |
7:20 pm - 7:30 pm | Discussion |
8:00 pm | Dinner |
FRIDAY |
7:30 am - 8:30 am | Breakfast |
9:00 am | Departure |